Best Pharmaphorum Podcasts (2024)

1
Structuring the unstructured: Deterministic AI and white box data cleanliness 18:31

5h ago18:31

18:31

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jane Reed, director of life sciences at Linguamatics, an IQVIA company, to discuss some of the major barriers preventing researchers from accessing the data they need to advance drug discovery and development and address safety concerns – and just how AI technologies can assist.…

1
People need to know how to use AI now 31:19

3d ago31:19

31:19

With the implementation of advancing technologies in industry comes the parallel need for suitable upskilling of the workforce – but this doesn’t as yet always pan out, and in today’s pharmaphorum podcast COO of Enthought Mike Connell discusses the growing skills gap in R&D in life sciences and the 80/20 rule with web editor Nicole Raleigh, as well…

1
Chronic cough and the patient voice 14:09

7d ago14:09

14:09

Chronic cough impacts up to 10% of the adult population and has a physical, psychological, and social impact on patients’ lives. Farrell Simon, chief commercial officer at Trevi Therapeutics, joins web editor Nicole Raleigh on the pharmaphorum podcast to discuss prioritising patients in clinical and commercial development, with an especial focus on…

1
Approaching the regulatory world with passion: CERs and EU MDR processes 21:46

15d ago21:46

21:46

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ethan Drower, co-founder and CEO of Cite Medical Solutions, a company providing full Clinical Evaluation Report (CER) services and industry literature review for European Union Medical Device Regulation (or EU MDR) processes.By pharmaphorum

1
Patient engagement throughout the product lifecycle 28:34

19d ago28:34

28:34

One of the things that makes patient engagement for pharma companies so challenging is that it's not something that can be added to one step of a process and then checked off the list. Real patient engagement needs to be integrated into processes every step of the way. In today's podcast, brought to you by Reverba, Reverba CEO Cheryl Lubbert joins …

1
The empowerment of data and predictive outcome models 21:32

23d ago21:32

21:32

In today’s podcast, web editor Nicole Raleigh speaks with Carolyn Ward, director of clinical strategy at Particle Health Inc, a data transformation platform for healthcare, enabling organisations across the care continuum to turn medical records into actionable insights.By pharmaphorum

1
The burden of diabetic vision loss in the West 17:24

26d ago17:24

17:24

In today’s podcast, web editor Nicole Raleigh welcomes Dr Catherine Beech, CEO of Exonate, for a discussion on retinal vascular disease and a potential eye drop treatment for diabetic retinopathy and diabetic macular oedema, instead of invasive injections into the eye.By pharmaphorum

1
Tips for on-time tech transfers that stay below budget 25:09

28d ago25:09

25:09

When it comes to life sciences manufacturing, there's nothing quite so daunting as a tech transfer - moving a product from development to commercialisation, or to a new facility or CDMO, presents many obstacles that have to be well thought out and planned. Delivering a tech transfer on schedule that stays below budget is no easy feat, but with the …

1
Clinical trial trends and the rise of site networks 29:28

1M ago29:28

29:28

We've recently passed the midpoint of 2024, so it's a good time to check in on trends – in this case, trends in the clinical trial space. In today's podcast, brought to you by Advanced Clinical, host Jonah Comstock is joined by Jason Casarella, EVP of business development and marketing at Advanced Clinical and Caroline Redecker, chief strategy offi…

1
A spectrum of obesity requires precision 23:47

1M ago23:47

23:47

In this latest pharmaphorum podcast, web editor Nicole Raleigh speaks with Michael Kyle, chief medical officer at Currax Pharmaceuticals – a company working to advance a greater understanding of how to effectively treat obesity – about perceptions and options beyond the bounds of GLP-1s, including evolution of hypertension treatments.…

1
The power and potential of regenerative medicine 20:02

1M ago20:02

20:02

The field of muscle stem cell research has been tangibly developing over the decades and in today’s pharmaphorum podcast wed editor Nicole Raleigh speaks with Dr Michael Rudnicki, co-founder and CSO of Satellos Biosciences, a company dedicated to developing novel therapeutics based on this science for those who live with Duchenne muscular dystrophy…

1
Leveraging data and AI for clinical trial success 15:25

2M ago15:25

15:25

In today’s pharmaphorum podcast, Orr Inbar, co-founder and CEO of QuantHealth, a Tel Aviv-based AI-powered clinical trial design company, discusses how advances in data and AI can help.By pharmaphorum

1
The future of fertility and the vaginal microbiome 24:54

2M ago24:54

24:54

In a new episode of the pharmaphorum podcast - recorded back in March, during Women’s History Month - web editor Nicole Raleigh spoke with Johan van Hylckama Vlieg, co-founder and chief scientific officer of Freya Biosciences, a Series A-financed, clinical stage, microbial immunotherapy company in women’s health, discussing the role of the vaginal …

1
Sustainable innovation for patients, people, and planet 29:13

2M ago29:13

29:13

Sustainability is all important for the planet and its people, and in today’s podcast web editor Nicole Raleigh speaks with Harriet Lewis, director of public affairs and communications at Chiesi UK & Ireland, about how partnerships between the NHS and pharma industry can support the journey to more sustainable practices, from R&D and drug reimburse…

1
The new frontier of microbiome-directed human health 30:47

2M ago30:47

30:47

The microbiome is ever more frequently spoken about of late, and so the pharmaphorum podcast invited Leo Grady, founder and CEO of Jona, to speak about at-home personal microbiome profiling, uncovering the relationship between human health and the gut.By pharmaphorum

1
Global medicines and the future outlook 28:39

2M ago28:39

28:39

In a conversation held earlier in the year as the four-year anniversary of the pandemic approached, the pharmaphorum podcast had as guest Murray Aitken, executive director of the IQVIA Institute for Human Data Science, to discuss the state of global medicines and the future outlook when it comes to research and development, and usage and spending a…

1
Purity, potency, and safety – affordably – in stem cell therapy 28:25

2M ago28:25

28:25

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh discusses stem cell therapy, and accessibility to and affordability of such treatment, with Rafael R Carazo Salas, founder and CEO of CellVoyant, an AI-first biotechnology company spun out from the University of Bristol.By pharmaphorum

1
The art of software 27:12

3M ago27:12

27:12

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Rob Pears, VP and head of automotive, manufacturing, and life sciences at Capgemini, which partners with companies to transform and manage their business by harnessing the power of technology.By pharmaphorum

1
Move over CAR-T: The potential of NK cells in cell therapy 34:31

3M ago34:31

34:31

On today’s podcast, Dr. Fred Aslan, CEO of Artiva Biosciences, joins host Jonah Comstock to talk more about this newer avenue in cell therapy. They discuss the potential of NK cells to provide effective allogeneic cell therapy, the potential of the therapy in auto-immune disease, and the importance of a robust manufacturing process that can get a h…

1
Working for a mature form of genomic medicines 20:08

3M ago20:08

20:08

In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.By pharmaphorum

1
Challenges and opportunities in synthetic clinical trials 44:01

3M ago44:01

44:01

On today’s episode Web Sun, president and cofounder of Komodo Health and Tracy Mayne, SVP regulatory and life sciences research at Slipstream IT, talk about this trend, where the industry is now, and what they’re doing to move it along.By pharmaphorum

1
The commercialisation of quantum science in pharma 26:03

3M ago26:03

26:03

In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.By pharmaphorum

1
Conference report: Reuters Pharma Europe 37:25

3M ago37:25

37:25

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.By pharmaphorum

1
In vitro gametogenesis: the science has to be right, and it has to be safe 16:46

3M ago16:46

16:46

Today’s podcast sees web editor Nicole Raleigh speak with Dr Mark Leondires, founder and medical director at Illume Fertility, who shares his own journey and insights on In vitro gametogenesis (IVG).By pharmaphorum

1
Proving ROI for digital endpoints 32:58

3M ago32:58

32:58

Jennifer Goldsack of DiME talks in this podcast about the ROI for digital endpoints for pharma. Data shows digital endpoints drives meaningful engagement with healthcare providers.By pharmaphorum

1
Clinical trials: their design, location, and, potentially, their simulation 17:09

3M ago17:09

17:09

Clinical trials, their design and location, and these days their simulation, are the focus of today’s podcast with Dr Gen Li, founder and president of Phesi.By pharmaphorum

1
Pace, acceleration, and precision are the name of the game 20:34

4M ago20:34

20:34

Security and privacy within biotech are critical points of consideration and discussion as the industry continues to innovate at speed, and it is such aspects that are central to today’s podcast with Zach Powers, chief information security officer at Benchling, the R&D cloud platform for the biotech industry.…

1
Technology working as the puzzle piece to bring better outcomes to patients 18:28

4M ago18:28

18:28

While at Reuters Pharma Europe in Barcelona the other week, pharmaphorum web editor Nicole Raleigh spoke with Florian Schnappauf, VP of enterprise commercial strategy at Veeva Europe, about commercial strategy and digitalising commercial operations.By pharmaphorum

1
Is precision psychiatry possible? 35:38

4M ago35:38

35:38

On today’s podcast, host Jonah Comstock is joined by Dr Amit Etkin, founder and CEO of Alto Neuroscience, a recently IPO'd biotech that wants to bring precision medicine to psychiatry. But what do we mean when we talk about precision, especially in a discipline like mental health that has historically involved a lot of objectivity?…

1
Encouraging early engagement to revitalise Europe’s pharmaceutical landscape 19:31

4M ago19:31

19:31

In an on-site interview at Reuters Pharma Europe in Barcelona, this week’s podcast saw Tommy Bramley, SVP of market access and healthcare consulting at Cencora, discuss revitalising Europe’s pharmaceutical landscape and leveraging legislation for health and competitiveness.By pharmaphorum

1
Predictions for AI in mental health in the coming year 22:35

4M ago22:35

22:35

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomes Dr Carl Marci, chief psychiatrist and managing director of mental health and neuroscience at OM1 to discuss predictions for AI in mental health in the coming year, as well as what might truly make a difference in the field and lessen the mental health crisis.…

1
Fixing clinical trial data management 26:34

4M ago26:34

26:34

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.…

1
Harnessing the velocity of biopharmaceutical advances 18:10

4M ago18:10

18:10

On today's episode of the podcast CEO and co-founder of 908 Devices Kevin Knopp joins as guest, discussing how such acceleration is by virtue of technological advancements, including the buzzword artificial intelligence (AI) and machine learning when it comes to bioprocessing.By pharmaphorum

1
Conference report: Reuters Pharma USA 38:02

5M ago38:02

38:02

Last week, pharmaphorum Editor in Chief Jonah Comstock traveled to Philadelphia for Reuters Pharma USA. On today’s podcast, he chats with guest host and Deep Dive Editor Eloise McLellan about his biggest takeaways from the two-day event.By pharmaphorum

1
The future of AI: Machine learning working together with scientific expertise 10:28

5M ago10:28

10:28

In a new episode of the pharmaphorum podcast recorded live on site at WIRED Health in London in March, web editor Nicole Raleigh spoke with Elise de Reus, co-founder of Cradle, the generative AI platform that helps scientists to design and program proteins.By pharmaphorum

1
Understanding the politics of drug pricing in the United States 35:53

5M ago35:53

35:53

Everyone says they want more affordable drugs for patients that need them, but people disagree quite a bit on who's to blame for the current status quo of sky-high prescription prices – not to mention how they might be corrected. To help unpack some of those trends and conflicting perspectives, Brandon Newman, CEO of healthcare analytics firm Xevan…

1
Female leadership and lessening disease burden 14:59

5M ago14:59

14:59

As Women’s History Month comes to its final week, today’s podcast sees web editor Nicole Raleigh in conversation with Debra Weiss, COO of the Bill & Melinda Gates Medical Research Institute (Gates MRI), discussing her role as a female leader in the leader and the non-profit organisation’s work in developing novel biomedical interventions and lessen…

1
The unique clinical trial challenges faced by digital therapeutics 27:56

5M ago27:56

27:56

On today’s podcast, host Jonah Comstock is joined by Meri Beckwith, cofounder of Lindus Health, a next-gen CRO that includes digital therapeutics among its specialties. They talk a little bit about often unseen difficulties of validating a digital therapeutic through a clinical trial.By pharmaphorum

1
The unmentionables: Challenging inequalities in women’s health 47:42

5M ago47:42

47:42

As Women’s History Month continues, pharmaphorum web editor Nicole Raleigh welcomed a group of expert individuals onto the podcast to discuss not just the inequalities in women’s health, but female leaders within life sciences, too. The guests included: Trine Bartholdy, chief innovation executive at the BioInnovation Institute (BII) in Denmark; Kar…

1
The next chapter for AI protein structure prediction 28:01

5M ago28:01

28:01

On today’s pharmaphorum podcast, Glen Gowers, cofounder of Basecamp Research, gets into the company’s recent pre-print paper and how it improves upon AlphaFold 2, the current gold standard for protein folding prediction.By pharmaphorum

1
Avoiding the data swamp: The transformative power of AI 17:56

5M ago17:56

17:56

In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern data platform and Cloud infrastructure for science, to discuss the evolving role of the Cloud in biopharma and some rather revolutionary tools in AI drug discovery.…

1
How natural language processing can make a difference in pharma 22:32

6M ago22:32

22:32

On today’s podcast, host Jonah Comstock welcomes Jane Reed, director of life sciences at IQVIA NLP, the new name for recent IQVIA acquisition Linguamatics. Jane talks through some of these different technologies and use cases and describes how natural language processing has exciting potential in translating real-world conversations on social media…

1
Transitioning from traditional surgical methods to the innovative use of stem cells. 18:35

6M ago18:35

18:35

In today’s podcast, host Nicole Raleigh welcomes Dr Jeffrey Gross, founder of ReCELLebrate, neurological surgeon, and expert in the field of regenerative medicine, to discuss this development. Their conversation delves into the recent appetite for the use of stem cells for longevity and explores the ‘health span’ notion that is being ever more freq…

1
The 2024 biopharma M&A landscape: An overview 31:28

6M ago31:28

31:28

It's been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats. On today’s podcast, host Jonah Comstock is joined by Cody Powers, principal of portfolio and business development at ZS Associates, to discuss those trends and predictions an…

1
Accelerating the process, transforming therapies and advancing precision medicine 22:00

6M ago22:00

22:00

In this episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Mohit Jain, founder and CEO of Sapient, a biomarker discovery lab providing expert services and actionable insights to better personalise disease prediction, diagnostics, and therapies.By pharmaphorum

1
Applying genetics to chemistry to find new small molecules 28:04

6M ago28:04

28:04

For all the advances that have been made in it, drug discovery is still a hit or miss process, as much an art as a science. But new technologies are changing that, allowing companies to approach the process with more precise eye. On today’s episode of the pharmaphorum podcast, Jason Park, CEO of Empress Therapeutics, discusses his company's novel a…

1
Opening the digital front door to advanced healthcare 54:38

6M ago54:38

54:38

In a new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with Dr Brigham Hyde, co-founder and CEO of Atropos Health, and Ardy Arianpour, co-founder and CEO of SEQSTER, about their latest partnership, with its goal of personalised registries and the notion of the digital front door for patient information.…

1
Pharmaceutical research in space 25:46

6M ago25:46

25:46

On today’s podcast, host Jonah Comstock welcomes Christina Corridon, global lead of oncology at ZS Associates and Sandeep Sangwan, who leads the knowledge services R&D team at ZS. They discuss how research conducted in space can advance life sciences research, especially in oncology.By pharmaphorum

1
Precision medicine in mental health - one size really doesn’t fit all 23:55

6M ago23:55

23:55

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomed Dr Hans Eriksson, chief medical officer at HMNC Brain Health, a precision psychiatry biopharma company, to discuss his work exploring current studies into the use of ketamine in mental health, HMNC Brain Health having last year announced topline results from a Phase 2 s…

1
Where are the pharma voices in US politics? 31:45

6M ago31:45

31:45

In today’s episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Jirair Ratevosian, a candidate for California’s 30th District with a doctorate in public health and experience leading infectious disease-fighting efforts for the Biden administration.By pharmaphorum

Podcasts Worth a Listen

Pharmaphorum Podcasts

Podcasts Worth a Listen

Quick Reference Guide